Dupilumab Plus Medium‐Dose Inhaled Corticosteroid (ICS) Improves Outcomes Compared With Placebo Plus Continued High‐Dose ICS in Children With Uncontrolled Moderate‐to‐Severe Type 2 Asthma

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Leonard B. Bacharier, Jorge F. Maspero, Nikolaos G. Papadopoulos, Rémi Gagnon, Theresa W. Guilbert, Changming Xia, Olivier Ledanois, Mena Soliman
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Pediatric Pulmonology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet